Answers are grounded in this paper and cite their sources.
Diltiazem (DTZ) is an anti-hypertensive and anti-anginal agent which is also used clinically as a metabolic inhibitor to reduce cyclosporin-A metabolism. The present communication describes an HPLC/UV method for measuring DTZ and 3 of its major metabolites. This method has a LOQ below 2.5 μg/L and within run CV's ranging from 11.3 to 1.9% at concentrations of 2.5 and 100 μg/L, and between-run CV's ranging from 10.5 to 4.9% at concentrations of 75 and 350 μg/L, respectively. The method has been applied successfully to 11 renal transplant recipients taking a variety of other drugs.
No takes yet. Share an insight, caveat, or question.
Morris et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: